Tashkin DP - Search Results

1

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators. Troosters T, et al. Among authors: tashkin dp. Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25. Eur Respir J. 2010. PMID: 20185426 Free article. Clinical Trial.

2

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators. Decramer M, et al. Among authors: tashkin dp. Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27. Lancet. 2009. PMID: 19716598 Clinical Trial.

3

Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease.

Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP; UPLIFT Study Investigators. Celli B, et al. Among authors: tashkin dp. Am J Respir Crit Care Med. 2009 Nov 15;180(10):948-55. doi: 10.1164/rccm.200906-0876OC. Epub 2009 Sep 3. Am J Respir Crit Care Med. 2009. PMID: 19729663 Clinical Trial.

4

Premature discontinuation during the UPLIFT study.

Decramer M, Molenberghs G, Liu D, Celli B, Kesten S, Lystig T, Tashkin DP; UPLIFT investigators. Decramer M, et al. Among authors: tashkin dp. Respir Med. 2011 Oct;105(10):1523-30. doi: 10.1016/j.rmed.2011.04.002. Epub 2011 May 6. Respir Med. 2011. PMID: 21530213 Free article. Clinical Trial.

5

Efficacy of tiotropium in COPD patients with FEV1 ≥ 60% participating in the UPLIFT® trial.

Tashkin DP, Celli BR, Decramer M, Lystig T, Liu D, Kesten S. Tashkin DP, et al. COPD. 2012 Jun;9(3):289-96. doi: 10.3109/15412555.2012.656211. Epub 2012 Mar 20. COPD. 2012. PMID: 22432932 Free article. Clinical Trial.

6

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease.

Celli BR, Decramer M, Lystig T, Kesten S, Tashkin DP. Celli BR, et al. Among authors: tashkin dp. Respir Res. 2012 Aug 6;13(1):66. doi: 10.1186/1465-9921-13-66. Respir Res. 2012. PMID: 22866681 Free PMC article. Clinical Trial.

7

Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.

Tashkin DP, Leimer I, Metzdorf N, Decramer M. Tashkin DP, et al. Respir Res. 2015 Jun 2;16(1):65. doi: 10.1186/s12931-015-0216-4. Respir Res. 2015. PMID: 26031308 Free PMC article. Clinical Trial.

8

Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial.

Celli BR, Decramer M, Liu D, Metzdorf N, Asijee GM, Tashkin DP. Celli BR, et al. Among authors: tashkin dp. Respir Res. 2016 May 4;17(1):48. doi: 10.1186/s12931-016-0361-4. Respir Res. 2016. PMID: 27141828 Free PMC article.

9

Effect of a single exacerbation on decline in lung function in COPD.

Halpin DMG, Decramer M, Celli BR, Mueller A, Metzdorf N, Tashkin DP. Halpin DMG, et al. Among authors: tashkin dp. Respir Med. 2017 Jul;128:85-91. doi: 10.1016/j.rmed.2017.04.013. Epub 2017 Apr 24. Respir Med. 2017. PMID: 28610675 Free article. Clinical Trial.

10

Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial.

Decramer M, Celli B, Tashkin DP, Pauwels RA, Burkhart D, Cassino C, Kesten S. Decramer M, et al. Among authors: tashkin dp. COPD. 2004;1(2):303-12. doi: 10.1081/copd-200026934. COPD. 2004. PMID: 17136995 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

554 results

Search Page

Filters